Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic.

COVID-19 Humans Lung Diseases, Interstitial / epidemiology Pandemics Retrospective Studies SARS-CoV-2
COVID-19 Clinical epidemiology Interstitial lung diseases Lung fibrosis

Journal

Respiratory investigation
ISSN: 2212-5353
Titre abrégé: Respir Investig
Pays: Netherlands
ID NLM: 101581124

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 28 05 2020
revised: 06 08 2020
accepted: 19 08 2020
pubmed: 27 9 2020
medline: 26 11 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

Patients with interstitial lung diseases (ILD) can be suspected to be at risk of experiencing a rapid flare-up due to COVID-19. However, no specific data are currently available for these patients. We retrospectively analyzed a cohort of 401 patients with ILD and determined the proportion of patients hospitalized for proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and specific symptoms of COVID-19. We found that 1% of patients (n = 4) were hospitalized (1 in ICU) for COVID-19. In total, 310 of the 401 patients answered the phone call. Only 33 patients (0.08%) experienced specific symptoms of SARS-CoV-2 infection. Our study did not demonstrate any increased occurrence of severe COVID-19 in ILD patients compared to the global population. Based on our findings, we could not make any conclusion on the incidence rate of SARS-CoV-2 infection in patients with ILDs, or on the overall outcome of immunocompromised patients affected by COVID-19.

Identifiants

DOI: 10.1016/j.resinv.2020.08.006 PMID: 32978099 PMC: PMC7501770
pubmed: 32978099
pii: S2212-5345(20)30124-6
doi: 10.1016/j.resinv.2020.08.006
pmc: PMC7501770
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-439

Investigateurs

A Ancion (A)
A Bouquegneau (A)
C Bovy (C)
G Darcis (G)
J O Defraigne (JO)
B Duysinx (B)
A Ghuysen (A)
A Gilbert (A)
V Heinen (V)
B Lambermont (B)
O Malaise (O)
M Martin (M)
B Misset (B)
M Moutschen (M)
D Nguyen Dang (D)
J Piazza (J)
J Szecel (J)
F Vaillant (F)
H Van Cauwenberge (H)
C Von Frenckell (C)
L Vroonen (L)

Informations de copyright

Copyright © 2020 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest None.

Auteurs

J Guiot (J)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium. Electronic address: J.Guiot@chuliege.be.

M Henket (M)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

A N Frix (AN)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

M Delvaux (M)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

A Denis (A)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

L Giltay (L)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

M Thys (M)

Department of Medico-economic Information, University Hospital of Liège, Liège, Belgium.

F Gester (F)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

M Moutschen (M)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, Liège, Belgium.

J L Corhay (JL)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

R Louis (R)

Pneumology Department, CHU Liège, Domaine Universitaire Du Sart-Tilman, B35, B4000 Liège, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Single-center experience of patients with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Single-center experience of patients with...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies pulmonaires › Pneumopathies interstitielles › Single-center experience of patients with...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Single-center experience of patients with...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Single-center experience of patients with...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Single-center experience of patients with...